Wasatch Advisors’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,974,228
| Closed | -$10.4M | – | 266 |
|
|
2022
Q1 | $10.4M | Buy |
2,974,228
+1,200,538
| +68% | +$4.21M | 0.05% | 182 |
|
|
2021
Q4 | $11.8M | Buy |
1,773,690
+341,762
| +24% | +$2.28M | 0.05% | 200 |
|
|
2021
Q3 | $14.3M | Buy |
1,431,928
+786,148
| +122% | +$7.85M | 0.06% | 190 |
|
|
2021
Q2 | $19.9M | Buy |
645,780
+379,467
| +142% | +$11.7M | 0.08% | 180 |
|
|
2021
Q1 | $11.6M | Buy |
266,313
+56,618
| +27% | +$2.47M | 0.05% | 196 |
|
|
2020
Q4 | $9.72M | Buy |
+209,695
| New | +$9.72M | 0.05% | 181 |
|